StemCells files shelf registration statement for $100M in debt and equity
Clinical-stage biotechnology company StemCells, Inc. (Nasdaq:STEM) said this morning that it filed a universal shelf registration statement with the U.S. Securities and Exchange Commission to issue up to $100 million of debt and equity securities.
Shares were halted in pre-market trading. For detailed price information and recent news stories about StemCells, click STEM.
